MS pharm word slides - PowerPoint PPT Presentation

1 / 12
About This Presentation
Title:

MS pharm word slides

Description:

Used with anesthesia to provide analgesia. ... Benzodiazepines:diazepam, lorazepam, midazolam. Barbiturates: secobarbital, pentobarbital ... – PowerPoint PPT presentation

Number of Views:41
Avg rating:3.0/5.0
Slides: 13
Provided by: donaldm3
Category:

less

Transcript and Presenter's Notes

Title: MS pharm word slides


1
  • Anesthetics and Anesthetic Adjuncts
  • Analgesics Opiates, fentanyl (Sublimaze)
  • General depressants
  • a. Benzodiazepines benzodiazepines midazolam
    (Versed)
  • b. Barbiturates secobarbital
  • Neuroleptics droperidol (Inapsine)
  • Muscarinic blockers (atropine, scopolomine,
    glycopyrate)
  • Neuromuscular blockers (paralytics)
  • Miscellaneous Agents (antagonists naloxone,
    flumazanil, neostigmine)

2
Analgesics
  • Used with anesthesia to provide analgesia.
  • Important ADRs respiratory depression,
    cardiovascular depression.
  • Potent Analgesics (opiates) morphine, fentanyl,
    nalbuphine, alfentanil, sufentanil.

3
Pre-Anesthetic Depressants
  • Benzodiazepinesdiazepam, lorazepam, midazolam
  • Barbiturates secobarbital, pentobarbital
  • Mechanism - enhancement of GABA action.

4
Neuroleptics
  • Antipsychotic agents droperidol
  • Produces a trance-like state, for neuroleptic
    anesthesia.
  • Effective antiemetics

5
  • Antagonists of Adjuncts to Anesthesia
  • ChEI - competitive NMBs
  • Naloxone - opiates
  • Flumazenil - BZD

6
Miscellaneous Drugs
  • anticholinergic agents atropine, scopolamine,
    glycopyrrolate.
  • Use to reduce secretions.

7
GABAA Receptors
  • The GABAA receptor is a heteromeric-pentamer.
  • Binding of GABA to its site on the GABAA receptor
    opens the chloride channel generally resulting in
    an IPSC (hyperpolarizing the postsynaptic neuron
    reducing excitation).
  • At least 21 different subunits have been
    identified.
  • Specific GABAA subunit combinations define the
    nature of the BDZ response.
  • Different subtype combinations appear to mediate
    the different actions of BDZs, including amnesia,
    anxiolysis, sedation, antispasticity.
  • Midazolam has twice the affinity for BDZ
    receptors than does diazepam.
  • The antianxiety action of BDZs may be a result of
    their ability to selectively block subunit
    constructs found in cortical and limbic arousal
    following stimulation of the reticular pathways.

8
Midazolam
  • Midazolam is a short-acting benzodiazepine.
  • Midazolam is used for conscious sedation,
    anxiolysis, and amnesia during minor surgical or
    diagnostic procedures.
  • Midazolam is used as an inducing agent, and as an
    adjunct to regional anesthesia.
  • Midazolam, as other benzodiazepines (BDZs) act at
    limbic, thalamic, and hypothalamic structures
    producing a dose dependant CNS depression
    including sedation, hypnosis, skeletal muscle
    relaxation, and anticonvulsant activity.
  • BDZs act by potentiating the action of GABA at
    GABAA receptors. Benzodiazepines cause allosteric
    modulation of GABAA receptor complex, but do not
    activate the channel.
  • Unlike barbiturates which augment GABA responses
    by increasing the length of time that chloride
    channels remain open, BDZs enhance GABA efficacy
    by increasing the affinity of GABA to its binding
    site on the GABAA receptor.

9
Propofol
  • Propofol (2,6-diisopropylphenol) is an
    intravenous anesthetic.
  • Propofol induces anesthesia that can be
    maintained by continuous infusion.
  • Propofol induces anesthesia as quickly as
    thiopental, but emergence from anesthesia is 10
    times more rapid than with thiopental and is
    associated with minimal postoperative confusion.
  • Only desflurane has a more rapid recovery time
    than propofol, but desflurane is associated with
    more nausea/vomiting. Unlike many other general
    anesthetics, propofol possesses an antiemetic
    action.
  • Propofol acts by binding to unique a3/a5
    containing GABAA receptor subunit constructs.
  • Propofol anesthesia is immediate and short-lived.
  • Cardiorespiratory depression, apnea and
    significant hypotension are possible and are
    dose-related.

10
Fentanyl
  • Fentanyl is a potent synthetic opiate agonist.
  • Fentanyl is a phenylpiperidine derivative,
    structurally similar to meperidine,
  • Fentanyl is highly lipid soluble.
  • Fentanyl is used to aid induction and maintenance
    of general anesthesia and to supplement regional
    and spinal analgesia.
  • Fentanyl is preferred to morphine in anesthesia
    due to its ability to attenuate hemodynamic
    responses and maintain cardiac stability.
  • Fentnayl may be administered alone or in
    combination with inhaled anesthetics, local
    anesthetics such as bupivacaine, or
    benzodiazepines.

11
Fentanyl Mechanism of Action
  • Fentanyl is a strong agonist at µ- and kappa-
    opiate receptors.
  • Opioids close N-type voltage-operated calcium
    channels (kappa-receptor agonist) and open
    calcium-dependent inwardly rectifying potassium
    channels (µ and delta receptor agonist) resulting
    in hyperpolarization and reduced neuronal
    excitability.
  • Analgesia is mediated through changes in the
    perception of pain at spinal cord (µ2-, delta-,
    kappa-receptors) and brain (µ1- and kappa3
    receptors).
  • Opiate receptors are G-protein coupled receptors.
    Opioid-G-protein systems include cAMP and
    PLC-intositol triphosphate.
  • The emotional response to pain is altered.
    Opiates do not alter the pain threshold of
    afferent nerve endings to noxious stimuli.
  • Opioids can modulate the endocrine and immune
    systems inhibiting release of vasopressin,
    somatostatin, insulin and glucagons.
  • Stimulatory effects of opioids are the result of
    "disinhibition" as the release of inhibitory
    neurotransmitters such as GABA is blocked.

12
Opiate Actions
  • Clinically, stimulation of µ-receptors produces
    analgesia, euphoria, respiratory depression,
    miosis, decreased gastrointestinal motility, and
    physical dependence.
  • Kappa-receptor stimulation produces analgesia,
    miosis, respiratory depression, as well as,
    dysphoria and some psychomimetic effects (i.e.,
    disorientation and/or depersonalization).
  • Miosis is produced by excitatory action on the
    autonomic segment of the nucleus of the
    oculomotor nerve.
  • Opiate-induced respiratory depression is caused
    by direct action on brain stem. respiratory
    centers while bradycardia is due to depression of
    the medullary vasomotor center and vagal nucleus
    stimulation.
  • Opiate agonists action on the GI tract results in
    constipation and delayed digestion, while urinary
    smooth muscle tone is increased by opiate
    agonists, sometimes causes urinary retention.
Write a Comment
User Comments (0)
About PowerShow.com